Patterns of and Rationale for the Co-use of Methamphetamine and Opioids
Findings From Qualitative Interviews in New Mexico and Nevada
Bibliographic Data
| ID | 15519845 |
|---|---|
| Authors | Brittany D Rhed (University of Nevada, Reno), Robert W Harding (0000-0001-6051-065X, University of Nevada, Reno), Charles Marks (0000-0002-3893-1914, University of Nevada, Reno), Katherine Wagner (0009-0004-4855-9513, University of Nevada, Reno), Phillip Fiuty (0000-0002-6166-8042, University of New Mexico), Kimberly Page (0000-0002-7120-1673, University of Nevada, Reno), K D Wagner (0000-0002-8614-2004, University of Nevada, Reno, corresponding author) |
| Year | 2022 |
| Volume | 13 |
| Pages | 824940-824940 |
| Publication date | 2022-03-28 |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Frontiers in Psychiatry (JOURNAL) |
| Journal identifiers | ISSN: 1664-0640 • E-ISSN: 1664-0640 |
| Publisher | Frontiers Media (PUBLISHER • CH) |
| DOI | 10.3389/fpsyt.2022.824940 |
| PMID | 35418887 |
| OpenAlex | W4220921424 |
| Language | EN |
| Citations received | 5 |
| References cited | 14 |
To address the emergent trend of increasing methamphetamine-related deaths, researchers, health care professionals, and community health workers must acknowledge the decision-making processes behind co-use of opioids and methamphetamine, including the perceived benefits and harms of co-use. There is an urgent need to address underlying issues associated with drug use-related harms, and to design interventions and models of treatment that holistically address participants' concerns
Addiction · Drug · Heroin · Medical prescription · Methadone · Methamphetamine · Opioid · Opioid use disorder · Psychiatry · Medicine · Opioid Use Disorder Treatment · Prenatal Substance Exposure Effects · Psychology · Substance Abuse Treatment and Outcomes · Internal Medicine · Pharmacology
Differential Associations Between Increasing Opioid Withdrawal Symptoms and More Frequent Methamphetamine Use, US, 2022–2023
Motivations for Polysubstance Use with Methamphetamine and Opioids Among People Who Use Drugs in Seattle, WA
Non‐Medical Use of Prescription Stimulants in Australia
Associations of hepatitis C virus (HCV) antibody positivity with opioid, stimulant, and polysubstance injection among people who inject drugs (PWID) in rural U.S. communities
Safety strategies and harm reduction for methamphetamine users in the era of fentanyl contamination
Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence
Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence
The rise of illicit fentanyls, stimulants and the fourth wave of the opioid overdose crisis
Twin epidemics
“It’s Crazy What Meth Can Help You Do”
Methamphetamine Use and Its Correlates among Individuals with Opioid Use Disorder in a Midwestern U.S. City
The Pastoral Clinic
Development and Validation of the Amphetamine-Type Stimulants Motive Questionnaire in a Clinical Population
Functional methamphetamine use
Methamphetamine use and methadone maintenance treatment
Lay knowledge and practices of methamphetamine use to manage opioid-related overdose risks
Co-use of methamphetamine and opioids among people in treatment in Oregon
Rethinking risk
Risk Factors for Nonfatal Overdose at Seattle-Area Syringe Exchanges
| Citations per year | 2.5 |
|---|---|
| Citation span | 2024 - 2026 (3) |
| Highly cited | No |